May 11, 2007 — Results of longer follow-up of patients randomized to early vs delayed treatment with interferon beta-1b (Betaseron, Bayer HealthCare) in the Betaseron in Newly Emerging Multiple ...
In RRMS, the early course of the disease is characterised by intermittent relapses, and partial or complete recovery of function between exacerbations. The occurrence of relapses is a key measure of ...
Betaseron (interferon beta-1b) is a prescription drug used to treat certain types of multiple sclerosis (MS) and clinically isolated syndrome (CIS) in adults. The drug is given as an injection under ...
Treatment with interferon or with glatiramer acetate? This question arises for many patients who receive a diagnosis of multiple sclerosis (MS) for the first time. Until now, the choice between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results